Archives: Agenda

• Delving into the transformative impact of AI across the healthcare and life sciences ecosystem
• Exploring how AI technologies are revolutionizing drug discovery, enhancing clinical trial efficiency, and enabling more personalized patient care.
• Streamlining early-stage research and optimizing real-world applications in patient monitoring and therapeutic delivery
• How AI is paving the way for faster, more precise, and impactful healthcare solutions
• Insights into the latest AI-driven innovations and how these advancements are shaping the future of healthcare from concept to patient outcomes

• Find out when you can waive the need for Consent Forms
• When needed, ensure that Informed Consent Forms include key information
• Implement decentralized clinical trial elements to improve trial participant engagement, recruitment, enrollment, and retention

• Aligning vendor expertise with study needs
• Assessing operational transparency and communication
• Balancing innovation with compliance

• Showcasing and defending the clinical operations strategy and outcome for pivotal studies during Sponsor regulatory inspections as the culmination of years of intense and important work; or the “Super Bowl” of Clinical Operations
• Sharing best practices based on real-life examples, for surviving and thriving during FDA and EMA Sponsor regulatory inspections from the Clinical Operations viewpoint
• Collaborating with QA and other cross-functional partners for success
• Best practices in logistics and Clin Ops teamwork in advance of, during and after the inspections
• Common, recent findings related to Clinical Operations during inspections

• Begin with the end in mind: Termination Clause
• Identify and access file repositories
• Understand PII and security requirements
• Close out projects in the storage phase
• Secure vendor-backed documents and files
• Reconcile finances and finalize invoices
• Issue termination letters
• Complete contract close-out

• Aligning the clinical trial ecosystem to be operationally efficient and reduce delays in supply deliverables
• Fine-tuning the clinical supply vendor partnership: How can sponsors and service providers start using guidance in totality instead of in silos?
• Maintaining open communication with manufacturers to address precise trial needs and perfect demand planning
• Working in tandem across the trial ecosystem to better manage demands for increasingly complex clinical supply needs

• Learning criteria for identifying investigator aligned with study goals, device expertise and regulatory expectations
• Building relationships at clinical sites
• Effective training for investigators and site staff
• Optimizing the informed consent process